Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.035 | 0.6 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |